Furthermore, one of the challenging issues for lithium extraction is a high degree of variability in the chemical make-up of source material, with iron being one of the most challenging contaminants the DLE industry encounters. After experiencing iron contamination during operations, we flushed our material, and again, laboratory testing confirmed no loss of integrity or productive capacity of our proprietary absorbent material. The durability of our proprietary absorbent material clears a critical hurdle for the successful long-term development of the DLE industry. These results underscore our leadership in overcoming scalability challenges confounding our competitors.
https://internationalbatterymetals2023tf.q4web.com/news/news-details/2024/IBAT-Investor-Update-December-30-2024--Year-in-Review-and-2025-Outlook/default.aspxThis is what puts ASN at an advantage and make KOCH want to do a deal with us, imho
- Forums
- ASX - By Stock
- ASN
- Ann: Half Year Accounts 31 December 2024
ASN
anson resources limited
Add to My Watchlist
2.22%
!
4.6¢

Ann: Half Year Accounts 31 December 2024, page-138
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $63.78M |
Open | High | Low | Value | Volume |
4.4¢ | 4.6¢ | 4.3¢ | $61.60K | 1.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50000 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 106998 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.044 |
4 | 424577 | 0.043 |
6 | 963182 | 0.042 |
4 | 131993 | 0.041 |
4 | 380024 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 106998 | 2 |
0.047 | 225000 | 1 |
0.048 | 250000 | 1 |
0.049 | 560212 | 4 |
0.050 | 751316 | 5 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ASN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online